// App-Quantinova.ai

EP1259 : THE EFFECT OF MYELOMA INDUCTION THERAPY TYPE AND DURATION ON PERIPHERAL BLOOD STEM CELL HARVEST FOR AUTOLOGOUS STEM CELL TRANSPLANTATION

Researchers

Presenter

  • Charlotte Pawlyn

Principal Investigators

  • Tom Menzies

  • Faith Davies

  • Gordon Cook

  • Matthew Jenner

  • John Jones

  • Martin Kaiser

  • Roger Owen

  • Mark Drayson

  • David Cairns

  • Gareth Morgan

  • Graham Jackson

Medical Centers

  • Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, United Kingdom

  • Perlmutter Cancer Center at NYU Langone Health,New York,Stati Uniti

  • Institute for Cancer Research, London, United Kingdom

  • Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom

  • Brighton and Sussex Medical School, Brighton, United Kingdom

  • Department of Haematology, University of Newcastle, Newcastle-upon-Tyne, United Kingdom

  • University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom

  • HMDS, Leeds Cancer Centre, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom

Locations

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Multiple Myeloma

Biomarkers

  • Cluster of Differentiation 34

Drug/Treatment

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • Dexamethasone

  • Dekpak 13 Day Taperpak

  • Lenalidomide

  • carfilzomib Intravenous

  • Thalidomide

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved